Riverbridge Partners LLC increased its position in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 2.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,559,572 shares of the health services provider’s stock after acquiring an additional 34,261 shares during the period. Amedisys comprises about […]